Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-27 @ 8:36 PM
Study NCT ID:
NCT05805657
Status:
COMPLETED
Last Update Posted:
2025-10-23
First Post:
2023-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D012893', 'term': 'Sleep Wake Disorders'}, {'id': 'D021081', 'term': 'Chronobiology Disorders'}], 'ancestors': [{'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D012890', 'term': 'Sleep'}], 'ancestors': [{'id': 'D009424', 'term': 'Nervous System Physiological Phenomena'}, {'id': 'D055687', 'term': 'Musculoskeletal and Neural Physiological Phenomena'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'aharvey@berkeley.edu', 'phone': '5104736490', 'title': 'Dr. Allison Harvey, Professor of Clinical Psychology', 'organization': 'University of California, Berkeley'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'timeFrame': 'Through study completion, an average of 12 months.', 'description': 'Providers treated patients who could have been in either the immediate or UC-DT conditions. Therefore, we analyzed by collapsing across immediate and UC-DT for providers.', 'eventGroups': [{'id': 'EG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.', 'otherNumAtRisk': 8, 'deathsNumAtRisk': 8, 'otherNumAffected': 0, 'seriousNumAtRisk': 8, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.', 'otherNumAtRisk': 70, 'deathsNumAtRisk': 70, 'otherNumAffected': 0, 'seriousNumAtRisk': 70, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.', 'otherNumAtRisk': 8, 'deathsNumAtRisk': 8, 'otherNumAffected': 0, 'seriousNumAtRisk': 8, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.', 'otherNumAtRisk': 57, 'deathsNumAtRisk': 57, 'otherNumAffected': 0, 'seriousNumAtRisk': 57, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG004', 'title': 'Standard TranS-C - Providers', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nThese data reflect the characteristics of providers who delivered Standard TranS-C.', 'otherNumAtRisk': 6, 'deathsNumAtRisk': 6, 'otherNumAffected': 0, 'seriousNumAtRisk': 6, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG005', 'title': 'Adapted TranS-C - Providers', 'description': 'The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nThese data reflect the characteristics of providers who delivered Adapted TranS-C.', 'otherNumAtRisk': 47, 'deathsNumAtRisk': 47, 'otherNumAffected': 0, 'seriousNumAtRisk': 47, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep DisturbanceMeasurement Information System - Sleep Disturbance', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.'}, {'id': 'OG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.'}, {'id': 'OG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.'}, {'id': 'OG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.'}, {'id': 'OG004', 'title': 'Immediate TranS-C', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the immediate condition.'}, {'id': 'OG005', 'title': 'UC-DT', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the UC-DT condition.'}, {'id': 'OG006', 'title': 'Standard TranS-C', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG007', 'title': 'Adapted TranS-C', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG008', 'title': 'TranS-C', 'description': 'Collapsed across TranS-C condition (Standard, Adapted) and treatment condition (Immediate, UC-DT)'}], 'classes': [{'title': 'Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '66.67', 'spread': '6.44', 'groupId': 'OG000'}, {'value': '62.21', 'spread': '7.73', 'groupId': 'OG001'}, {'value': '60.54', 'spread': '5.63', 'groupId': 'OG002'}, {'value': '62.24', 'spread': '7.34', 'groupId': 'OG003'}, {'value': '62.71', 'spread': '7.69', 'groupId': 'OG004'}, {'value': '62.05', 'spread': '7.14', 'groupId': 'OG005'}, {'value': '63.81', 'spread': '6.66', 'groupId': 'OG006'}, {'value': '62.23', 'spread': '7.52', 'groupId': 'OG007'}, {'value': '62.40', 'spread': '7.42', 'groupId': 'OG008'}]}]}, {'title': 'Mid-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '49.55', 'spread': '2.33', 'groupId': 'OG000'}, {'value': '53.81', 'spread': '9.58', 'groupId': 'OG001'}, {'value': '53.60', 'spread': '9.39', 'groupId': 'OG004'}, {'value': '50.08', 'spread': '2.65', 'groupId': 'OG006'}, {'value': '55.10', 'spread': '9.27', 'groupId': 'OG007'}, {'value': '54.80', 'spread': '9.08', 'groupId': 'OG008'}]}]}, {'title': 'Post-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '51.05', 'spread': '15.23', 'groupId': 'OG000'}, {'value': '55.06', 'spread': '10.76', 'groupId': 'OG001'}, {'value': '61.48', 'spread': '10.37', 'groupId': 'OG002'}, {'value': '61.04', 'spread': '8.52', 'groupId': 'OG003'}, {'value': '54.74', 'spread': '11.04', 'groupId': 'OG004'}, {'value': '61.08', 'spread': '8.59', 'groupId': 'OG005'}, {'value': '54.21', 'spread': '12.22', 'groupId': 'OG006'}, {'value': '55.21', 'spread': '11.18', 'groupId': 'OG007'}, {'value': '55.12', 'spread': '11.19', 'groupId': 'OG008'}]}]}, {'title': '6-month follow-up', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '52.35', 'spread': '5.83', 'groupId': 'OG000'}, {'value': '52.48', 'spread': '10.34', 'groupId': 'OG001'}, {'value': '52.47', 'spread': '10.07', 'groupId': 'OG004'}, {'value': '54.86', 'spread': '6.74', 'groupId': 'OG006'}, {'value': '53.54', 'spread': '10.05', 'groupId': 'OG007'}, {'value': '53.63', 'spread': '9.84', 'groupId': 'OG008'}]}]}], 'analyses': [{'pValue': '<0.001', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-7.16', 'groupDescription': 'Immediate TranS-C (Standard/Adapted combined) versus UC-DT on change in sleep disturbance from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.52', 'groupIds': ['OG006', 'OG007'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '2.22', 'pValueComment': 'Standard TranS-C versus Adapted TranS-C on change in sleep disturbance from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.02', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-10.89', 'groupDescription': 'Acceptability of intervention measure (AIM) predicting sleep disturbance.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.04', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-6.26', 'groupDescription': 'Appropriateness of intervention measure (IAM) predicting sleep disturbance.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.001', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-10.37', 'groupDescription': 'Feasibility of intervention measure (FIM) predicting sleep disturbance.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, mid-treatment (2/4 weeks post-baseline), post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Scale. The 8-item short version scale assesses perceived sleep problems (e.g., sleep quality, perception of sleep difficulties) over a 7-day period. Items are rated on a 5-point scale ranging from 1 (not at all) to 5 (very much). Raw scores are summed to produce a single score, resulting in a range from 8 to 40. Raw scores are converted to t-scores using treatment manuals. T-scores range from 30.5 to 77.5. A T-score of 50 indicates the population mean with a standard deviation of 10. Higher scores indicate worse sleep disturbance.', 'unitOfMeasure': 'T-score', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Mid-treatment and 6-month follow-up assessments were collected following TranS-C but were not collected following Usual Care (UC-DT). To increase the sample size, analyses comparing Standard vs. Adapted TranS-C collapsed over immediate and UC-DT conditions (using the assessments collected after the UC-DT group started TranS-C at mid-treatment, post-treatment, and 6-month follow-up). An additional analysis also collapsed across all conditions.'}, {'type': 'PRIMARY', 'title': 'Provider-level Outcome: Acceptability Intervention Measure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '47', 'groupId': 'OG001'}, {'value': '53', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C - Providers', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.'}, {'id': 'OG001', 'title': 'Adapted TranS-C - Providers', 'description': 'The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.'}, {'id': 'OG002', 'title': 'TranS-C - Providers', 'description': 'Collapsed across Standard and Adapted TranS-C.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '4.90', 'spread': '0.22', 'groupId': 'OG000'}, {'value': '4.74', 'spread': '0.41', 'groupId': 'OG001'}, {'value': '4.76', 'spread': '0.39', 'groupId': 'OG002'}]}]}, {'title': 'Mid-treatment', 'categories': [{'measurements': [{'value': '5.00', 'spread': '0.00', 'groupId': 'OG000'}, {'value': '4.64', 'spread': '0.44', 'groupId': 'OG001'}, {'value': '4.65', 'spread': '0.44', 'groupId': 'OG002'}]}]}, {'title': 'Post-treatment', 'categories': [{'measurements': [{'value': '5.00', 'spread': '0.00', 'groupId': 'OG000'}, {'value': '4.54', 'spread': '0.58', 'groupId': 'OG001'}, {'value': '4.56', 'spread': '0.57', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, mid-treatment (2 weeks post-baseline for Adapted TranS-C and 4 weeks post-baseline for Standard TranS- C), post-treatment (4 weeks post-baseline for Adapted TranS-C and 8 weeks post-baseline for Standard TranS-C).', 'description': 'Assesses provider perceptions of the acceptability of the treatment intervention using a self-report questionnaire. The 4-item scale is rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). A total score is calculated by averaging all four items. Total scores range from 1 to 5, with higher scores indicating greater perceptions of acceptability.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Acceptability Intervention Measure was collected only from providers. To increase the sample size, and because providers treated patients who could have been in either the immediate or UC-DT conditions, we analyzed by collapsing across immediate and UC-DT for providers. For some analyses, data were collapsed across Standard and Adapted TranS-C. This measure was not assessed following usual care.'}, {'type': 'SECONDARY', 'title': 'Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.'}, {'id': 'OG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.'}, {'id': 'OG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.'}, {'id': 'OG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.'}, {'id': 'OG004', 'title': 'Immediate TranS-C', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the immediate condition.'}, {'id': 'OG005', 'title': 'UC-DT', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the UC-DT condition.'}, {'id': 'OG006', 'title': 'Standard TranS-C', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG007', 'title': 'Adapted TranS-C', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG008', 'title': 'TranS-C', 'description': 'Collapsed across TranS-C condition (Standard, Adapted) and treatment condition (Immediate, UC-DT).'}], 'classes': [{'title': 'Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '63.12', 'spread': '10.63', 'groupId': 'OG000'}, {'value': '60.30', 'spread': '8.57', 'groupId': 'OG001'}, {'value': '59.24', 'spread': '10.79', 'groupId': 'OG002'}, {'value': '60.09', 'spread': '8.58', 'groupId': 'OG003'}, {'value': '60.59', 'spread': '8.76', 'groupId': 'OG004'}, {'value': '59.98', 'spread': '8.79', 'groupId': 'OG005'}, {'value': '61.18', 'spread': '10.54', 'groupId': 'OG006'}, {'value': '60.20', 'spread': '8.54', 'groupId': 'OG007'}, {'value': '60.31', 'spread': '8.75', 'groupId': 'OG008'}]}]}, {'title': 'Mid-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '60.20', 'spread': '5.80', 'groupId': 'OG000'}, {'value': '55.67', 'spread': '10.66', 'groupId': 'OG001'}, {'value': '55.89', 'spread': '10.47', 'groupId': 'OG004'}, {'value': '55.83', 'spread': '8.82', 'groupId': 'OG006'}, {'value': '56.76', 'spread': '10.45', 'groupId': 'OG007'}, {'value': '56.70', 'spread': '10.30', 'groupId': 'OG008'}]}]}, {'title': 'Post-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '48.65', 'spread': '12.87', 'groupId': 'OG000'}, {'value': '52.80', 'spread': '11.90', 'groupId': 'OG001'}, {'value': '59.66', 'spread': '6.61', 'groupId': 'OG002'}, {'value': '57.71', 'spread': '8.58', 'groupId': 'OG003'}, {'value': '52.46', 'spread': '11.90', 'groupId': 'OG004'}, {'value': '57.88', 'spread': '8.39', 'groupId': 'OG005'}, {'value': '52.74', 'spread': '10.56', 'groupId': 'OG006'}, {'value': '53.54', 'spread': '11.14', 'groupId': 'OG007'}, {'value': '53.48', 'spread': '11.03', 'groupId': 'OG008'}]}]}, {'title': '6-month follow-up', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '50.75', 'spread': '9.05', 'groupId': 'OG000'}, {'value': '53.82', 'spread': '11.29', 'groupId': 'OG001'}, {'value': '53.62', 'spread': '11.12', 'groupId': 'OG004'}, {'value': '54.27', 'spread': '9.82', 'groupId': 'OG006'}, {'value': '54.71', 'spread': '10.90', 'groupId': 'OG007'}, {'value': '54.68', 'spread': '10.79', 'groupId': 'OG008'}]}]}], 'analyses': [{'pValue': '0.001', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-6.44', 'groupDescription': 'Treatment condition (Standard/Adapted TranS-C versus UC-DT) on change in sleep- related impairment from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.72', 'groupIds': ['OG006', 'OG007'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '1.36', 'groupDescription': 'Standard TranS-C versus Adapted TranS-C on change in sleep-related impairment from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.30', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-3.90', 'groupDescription': 'Acceptability of intervention measure (AIM) predicting sleep-related impairment.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.78', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '0.79', 'groupDescription': 'Appropriateness of intervention measure (IAM) predicting sleep-related impairment.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.15', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-4.45', 'groupDescription': 'Feasibility of intervention measure (FIM) predicting sleep-related impairment.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, mid-treatment (2/4 weeks post-baseline), post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Impairment Scale. The 8-item short version scale assesses perceived sleep problems during waking hours (e.g., alertness, sleepiness, tiredness) over a 7-day period. Items are rated on a 5-point scale ranging from 1 (not at all) to 5 (very much). Raw scores are summed to produce a single score, resulting in a range from 8 to 40. Raw scores are converted to t-scores using treatment manuals. T-scores range from 30.1 to 80.1. A T-score of 50 indicates the population mean with a standard deviation of 10. Higher scores indicate worse sleep-related impairment.', 'unitOfMeasure': 'T-score', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Mid-treatment and 6-month follow-up assessments were collected following TranS-C but were not collected following Usual Care (UC-DT). To increase the sample size, analyses comparing Standard vs. Adapted TranS-C collapsed over immediate and UC-DT conditions (using the assessments collected post TranS-C for the UC-DT group). An additional analysis also collapsed across all conditions.'}, {'type': 'SECONDARY', 'title': 'Patient-level Outcome: Composite Sleep Health Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.'}, {'id': 'OG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.'}, {'id': 'OG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.'}, {'id': 'OG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.'}, {'id': 'OG004', 'title': 'Immediate TranS-C', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the immediate condition.'}, {'id': 'OG005', 'title': 'UC-DT', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the UC-DT condition.'}, {'id': 'OG006', 'title': 'Standard TranS-C', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG007', 'title': 'Adapted TranS-C', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG008', 'title': 'TranS-C', 'description': 'Collapsed across TranS-C condition (Standard, Adapted) and treatment condition (Immediate, UC-DT).'}], 'classes': [{'title': 'Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '3.00', 'spread': '1.10', 'groupId': 'OG000'}, {'value': '2.25', 'spread': '1.29', 'groupId': 'OG001'}, {'value': '2.29', 'spread': '1.50', 'groupId': 'OG002'}, {'value': '2.45', 'spread': '1.47', 'groupId': 'OG003'}, {'value': '2.31', 'spread': '1.28', 'groupId': 'OG004'}, {'value': '2.43', 'spread': '1.46', 'groupId': 'OG005'}, {'value': '2.62', 'spread': '1.33', 'groupId': 'OG006'}, {'value': '2.33', 'spread': '1.37', 'groupId': 'OG007'}, {'value': '2.36', 'spread': '1.36', 'groupId': 'OG008'}]}]}, {'title': 'Mid-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '3.50', 'spread': '2.12', 'groupId': 'OG000'}, {'value': '3.28', 'spread': '1.54', 'groupId': 'OG001'}, {'value': '3.29', 'spread': '1.54', 'groupId': 'OG004'}, {'value': '3.50', 'spread': '1.73', 'groupId': 'OG006'}, {'value': '3.05', 'spread': '1.54', 'groupId': 'OG007'}, {'value': '3.08', 'spread': '1.55', 'groupId': 'OG008'}]}]}, {'title': 'Post-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '3.33', 'spread': '2.52', 'groupId': 'OG000'}, {'value': '3.07', 'spread': '1.59', 'groupId': 'OG001'}, {'value': '3.00', 'spread': '1.41', 'groupId': 'OG002'}, {'value': '2.66', 'spread': '1.45', 'groupId': 'OG003'}, {'value': '3.09', 'spread': '1.63', 'groupId': 'OG004'}, {'value': '2.69', 'spread': '1.44', 'groupId': 'OG005'}, {'value': '2.50', 'spread': '2.07', 'groupId': 'OG006'}, {'value': '3.07', 'spread': '1.52', 'groupId': 'OG007'}, {'value': '3.03', 'spread': '1.56', 'groupId': 'OG008'}]}]}, {'title': '6-month follow-up', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '4.00', 'spread': '1.41', 'groupId': 'OG000'}, {'value': '2.94', 'spread': '1.62', 'groupId': 'OG001'}, {'value': '3.02', 'spread': '1.62', 'groupId': 'OG004'}, {'value': '3.57', 'spread': '1.62', 'groupId': 'OG006'}, {'value': '2.90', 'spread': '1.52', 'groupId': 'OG007'}, {'value': '2.95', 'spread': '1.53', 'groupId': 'OG008'}]}]}], 'analyses': [{'pValue': '0.09', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '0.55', 'groupDescription': 'Treatment condition (Standard/Adapted TranS-C versus UC-DT) on change in Composite Sleep Health Score from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.11', 'groupIds': ['OG006', 'OG007'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '1.05', 'groupDescription': 'Standard TranS-C versus Adapted TranS-C on change in sleep health from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.59', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '0.45', 'groupDescription': 'Acceptability of intervention measure (AIM) predicting sleep health.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.14', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '0.72', 'groupDescription': 'Appropriateness of intervention measure (IAM) predicting sleep health.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.06', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '0.89', 'groupDescription': 'Feasibility of intervention measure (FIM) predicting sleep health.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, mid-treatment (2/4 weeks post-baseline), post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'Composite Sleep Health Score is defined as the sum of scores on 6 sleep health dimensions: Regularity (Midpoint sleep fluctuation across a 7-day sleep diary \\< 1 hour), Satisfaction (Sleep quality question on PROMIS-Sleep Disturbance (PROMIS = Patient-Reported Outcomes Measurement Information System)), Alertness (Daytime sleepiness question on PROMIS-Sleep Related Impairment (PROMIS = Patient-Reported Outcomes Measurement Information System)), Timing (Mean midpoint sleep across the 7 day sleep diary between 2 and 4 AM), Efficiency (Average sleep efficiency based on the 7 day sleep diary ≥ 85%), and Duration (Total Sleep Time average based on 7 day sleep diary between 7 and 9 hours). Each dimension was dichotomized such that 1 = good /yes; 0 = poor/no). Total composite sleep health score ranges from 0 to 6, with larger values indicating better sleep health.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Mid-treatment and 6-month follow-up assessments were collected following TranS-C but were not collected following Usual Care (UC-DT). To increase the sample size, analyses comparing Standard vs. Adapted TranS-C collapsed over immediate and UC-DT conditions (using the assessments collected after the UC-DT group started TranS-C at mid-treatment, post-treatment, and 6-month follow-up). An additional analysis also collapsed across all conditions.'}, {'type': 'SECONDARY', 'title': 'Patient-level Outcome: Sheehan Disability Scale', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.'}, {'id': 'OG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.'}, {'id': 'OG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.'}, {'id': 'OG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.'}, {'id': 'OG004', 'title': 'Immediate TranS-C', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the immediate condition.'}, {'id': 'OG005', 'title': 'UC-DT', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the UC-DT condition.'}, {'id': 'OG006', 'title': 'Standard TranS-C', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG007', 'title': 'Adapted TranS-C', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG008', 'title': 'TranS-C', 'description': 'Collapsed across TranS-C condition (Standard, Adapted) and treatment condition (Immediate, UC-DT).'}], 'classes': [{'title': 'Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '15.25', 'spread': '6.63', 'groupId': 'OG000'}, {'value': '12.49', 'spread': '7.72', 'groupId': 'OG001'}, {'value': '11.75', 'spread': '10.07', 'groupId': 'OG002'}, {'value': '11.88', 'spread': '7.04', 'groupId': 'OG003'}, {'value': '12.77', 'spread': '7.62', 'groupId': 'OG004'}, {'value': '11.86', 'spread': '7.38', 'groupId': 'OG005'}, {'value': '13.50', 'spread': '8.43', 'groupId': 'OG006'}, {'value': '12.21', 'spread': '7.40', 'groupId': 'OG007'}, {'value': '12.36', 'spread': '7.50', 'groupId': 'OG008'}]}]}, {'title': 'Post-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '6.50', 'spread': '6.35', 'groupId': 'OG000'}, {'value': '7.98', 'spread': '7.06', 'groupId': 'OG001'}, {'value': '10.80', 'spread': '7.66', 'groupId': 'OG002'}, {'value': '11.10', 'spread': '7.51', 'groupId': 'OG003'}, {'value': '7.86', 'spread': '6.95', 'groupId': 'OG004'}, {'value': '11.07', 'spread': '7.46', 'groupId': 'OG005'}, {'value': '8.86', 'spread': '7.73', 'groupId': 'OG006'}, {'value': '8.36', 'spread': '6.47', 'groupId': 'OG007'}, {'value': '8.40', 'spread': '6.54', 'groupId': 'OG008'}]}]}, {'title': '6-month follow-up', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '9.75', 'spread': '8.26', 'groupId': 'OG000'}, {'value': '8.51', 'spread': '7.06', 'groupId': 'OG001'}, {'value': '8.59', 'spread': '7.07', 'groupId': 'OG004'}, {'value': '9.71', 'spread': '8.46', 'groupId': 'OG006'}, {'value': '8.70', 'spread': '7.05', 'groupId': 'OG007'}, {'value': '8.77', 'spread': '7.11', 'groupId': 'OG008'}]}]}], 'analyses': [{'pValue': '0.002', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-4.33', 'groupDescription': 'Treatment condition (Standard/Adapted TranS-C versus UC-DT) on change in functional impairment from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.002', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Coefficient of indirect effect', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-2.20', 'ciLowerLimit': '-3.57', 'ciUpperLimit': '-0.83', 'groupDescription': 'Structural equation modeling (SEM) was used to test whether the relationship between TranS-C condition (Immediate vs. UC-DT) and functional impairment (Sheehan Disability Scale) at post was mediated by sleep disturbance (PROMIS-SD) at post. The parameter of interest was the indirect effect.', 'statisticalMethod': 'SEM', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.001', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Coefficient of indirect effect', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-2.76', 'ciLowerLimit': '-4.44', 'ciUpperLimit': '-1.08', 'groupDescription': 'Structural equation modeling (SEM) was used to test whether the relationship between TranS-C condition (Immediate vs. UC-DT) and functional impairment (Sheehan Disability Scale) at post was mediated by sleep-related impairment (PROMIS-SRI). The parameter of interest was the indirect effect at post', 'statisticalMethod': 'SEM', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.78', 'groupIds': ['OG006', 'OG007'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '0.84', 'groupDescription': 'Standard TranS-C versus Adapted TranS-C on change in functional impairment from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.49', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-1.41', 'groupDescription': 'Acceptability of intervention measure (AIM) predicting functional impairment.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.27', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-1.62', 'groupDescription': 'Appropriateness of intervention measure (IAM) predicting functional impairment.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.09', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-2.07', 'groupDescription': 'Feasibility of intervention measure (FIM) predicting functional impairment.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'The Sheehan Disability Scale (SDS) assesses impairment in work/school, social, and family life. Items are rated on a scale from 0 (not at all) to 10 (extremely). Items are summed to produce a single score. Scores range from 0 to 30, with higher scores indicating higher functional impairment.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': '6-month follow-up assessments were collected following TranS-C but were not collected following Usual Care (UC-DT). To increase the sample size, analyses comparing Standard vs. Adapted TranS-C collapsed over immediate and UC-DT conditions (using the assessments collected after the UC-DT group started TranS-C at post-treatment, and 6-month follow-up). An additional analysis also collapsed across all conditions.'}, {'type': 'SECONDARY', 'title': 'Patient-level Outcome: The Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.'}, {'id': 'OG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.'}, {'id': 'OG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.'}, {'id': 'OG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.'}, {'id': 'OG004', 'title': 'Immediate TranS-C', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the immediate condition.'}, {'id': 'OG005', 'title': 'UC-DT', 'description': 'Standard and Adapted TranS-C combined for participants randomized to the UC-DT condition.'}, {'id': 'OG006', 'title': 'Standard TranS-C', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG007', 'title': 'Adapted TranS-C', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately or after usual-care delayed treatment.'}, {'id': 'OG008', 'title': 'TranS-C', 'description': 'Collapsed across TranS-C condition (Standard, Adapted) and treatment condition (Immediate, UC-DT).'}], 'classes': [{'title': 'Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '25.38', 'spread': '8.93', 'groupId': 'OG000'}, {'value': '23.48', 'spread': '8.70', 'groupId': 'OG001'}, {'value': '18.75', 'spread': '5.18', 'groupId': 'OG002'}, {'value': '23.25', 'spread': '9.48', 'groupId': 'OG003'}, {'value': '22.69', 'spread': '9.15', 'groupId': 'OG004'}, {'value': '23.68', 'spread': '8.69', 'groupId': 'OG005'}, {'value': '22.06', 'spread': '7.84', 'groupId': 'OG006'}, {'value': '23.37', 'spread': '9.03', 'groupId': 'OG007'}, {'value': '23.23', 'spread': '8.89', 'groupId': 'OG008'}]}]}, {'title': 'Post-treatment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}, {'value': '57', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '65', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '14.00', 'spread': '10.68', 'groupId': 'OG000'}, {'value': '17.91', 'spread': '9.61', 'groupId': 'OG001'}, {'value': '20.60', 'spread': '5.32', 'groupId': 'OG002'}, {'value': '20.67', 'spread': '8.74', 'groupId': 'OG003'}, {'value': '17.59', 'spread': '9.64', 'groupId': 'OG004'}, {'value': '20.67', 'spread': '8.46', 'groupId': 'OG005'}, {'value': '16.14', 'spread': '8.07', 'groupId': 'OG006'}, {'value': '18.00', 'spread': '9.34', 'groupId': 'OG007'}, {'value': '17.84', 'spread': '9.20', 'groupId': 'OG008'}]}]}, {'title': '6-month follow-up', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '78', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '16', 'groupId': 'OG006'}, {'value': '127', 'groupId': 'OG007'}, {'value': '143', 'groupId': 'OG008'}]}], 'categories': [{'measurements': [{'value': '14.25', 'spread': '8.30', 'groupId': 'OG000'}, {'value': '18.47', 'spread': '10.16', 'groupId': 'OG001'}, {'value': '18.19', 'spread': '10.04', 'groupId': 'OG004'}, {'value': '17.29', 'spread': '7.20', 'groupId': 'OG006'}, {'value': '18.24', 'spread': '9.51', 'groupId': 'OG007'}, {'value': '18.18', 'spread': '9.34', 'groupId': 'OG008'}]}]}], 'analyses': [{'pValue': '0.002', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-4.25', 'groupDescription': 'Treatment condition (Standard/Adapted TranS-C versus UC-DT) on change in psychiatric symptoms from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.02', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Coefficient of indirect effect', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-1.95', 'ciLowerLimit': '-3.54', 'ciUpperLimit': '-0.36', 'groupDescription': 'Structural equation modeling (SEM) was used to test whether the relationship between TranS-C condition (Immediate vs. UC-DT) and psychiatric symptoms (Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure) at post was mediated by sleep disturbance (PROMIS-SD) at post. The parameter of interest was the indirect effect.', 'statisticalMethod': 'SEM', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.01', 'groupIds': ['OG004', 'OG005'], 'paramType': 'Coefficient of indirect effect', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-1.62', 'ciLowerLimit': '-2.87', 'ciUpperLimit': '-0.38', 'groupDescription': 'Structural equation modeling (SEM) was used to test whether the relationship between TranS-C condition (Immediate vs. UC-DT) and psychiatric symptoms (Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure) at post was mediated by sleep-related impairment (PROMIS-SRI) at post. The parameter of interest was the indirect effect.', 'statisticalMethod': 'SEM', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.56', 'groupIds': ['OG006', 'OG007'], 'paramType': 'Time by treatment interaction coeff.', 'ciNumSides': 'TWO_SIDED', 'paramValue': '1.79', 'groupDescription': 'Standard TranS-C versus Adapted TranS-C on change in psychiatric symptoms from pre to post.', 'statisticalMethod': 'Intent-to-treat, multilevel modeling', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.34', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-3.46', 'groupDescription': 'Acceptability of intervention measure (AIM) predicting psychiatric symptoms.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.01', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-5.54', 'groupDescription': 'Appropriateness of intervention measure (IAM) predicting psychiatric symptoms.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.01', 'groupIds': ['OG008'], 'paramType': 'Coefficient', 'ciNumSides': 'TWO_SIDED', 'paramValue': '-5.65', 'groupDescription': 'Feasibility of intervention measure (FIM) predicting psychiatric symptoms.', 'statisticalMethod': 'Regression, Linear', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'The Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure (DSM-5) assesses psychiatric symptoms across 13 mental health domains. Participants rate on a 5-point scale how often they were bothered by each symptom on a scale from 0 (not at all) to 4 (nearly every day). Scores range from 0 to 52, with higher scores indicating more severe symptoms.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': '6-month follow-up assessments were collected following TranS-C but were not collected following Usual Care (UC-DT). To increase the sample size, analyses comparing Standard vs. Adapted TranS-C collapsed over immediate and UC-DT conditions (using the assessments collected after the UC-DT group started TranS-C at mid-treatment, post-treatment, and 6-month follow-up). An additional analysis also collapsed across all conditions.'}, {'type': 'SECONDARY', 'title': 'Provider-level Outcome: Intervention Appropriateness Measure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '47', 'groupId': 'OG001'}, {'value': '53', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C - Providers', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.'}, {'id': 'OG001', 'title': 'Adapted TranS-C - Providers', 'description': 'The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.'}, {'id': 'OG002', 'title': 'TranS-C Providers', 'description': 'Collapsed across Standard and Adapted TranS-C.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '5.00', 'spread': '0.00', 'groupId': 'OG000'}, {'value': '4.79', 'spread': '0.35', 'groupId': 'OG001'}, {'value': '4.82', 'spread': '0.33', 'groupId': 'OG002'}]}]}, {'title': 'Mid-treatment', 'categories': [{'measurements': [{'value': '4.83', 'spread': '0.29', 'groupId': 'OG000'}, {'value': '4.56', 'spread': '0.52', 'groupId': 'OG001'}, {'value': '4.58', 'spread': '0.51', 'groupId': 'OG002'}]}]}, {'title': 'Post-treatment', 'categories': [{'measurements': [{'value': '4.75', 'spread': '0.50', 'groupId': 'OG000'}, {'value': '4.39', 'spread': '0.67', 'groupId': 'OG001'}, {'value': '4.41', 'spread': '0.67', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, mid-treatment (2 weeks post-baseline for Adapted TranS-C and 4 weeks post-baseline for Standard TranS- C), post-treatment (4 weeks post-baseline for Adapted TranS-C and 8 weeks post-baseline for Standard TranS-C).', 'description': 'Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire. The 4-item scale is rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). A total score is calculated by averaging all four items. Total scores range from 1 to 5, with higher scores indicating greater perceptions of appropriateness.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Intervention Appropriateness Measure was collected only from providers. To increase the sample size, and because providers treated patients who could have been in either the immediate or UC-DT conditions, we analyzed by collapsing across immediate and UC-DT for providers. For some analyses, data were collapsed across Standard and Adapted TranS-C. This measure was not assessed following usual care.'}, {'type': 'SECONDARY', 'title': 'Provider-level Outcome: Feasibility of Intervention Measure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '47', 'groupId': 'OG001'}, {'value': '53', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Standard TranS-C - Providers', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.'}, {'id': 'OG001', 'title': 'Adapted TranS-C - Providers', 'description': 'The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.'}, {'id': 'OG002', 'title': 'TranS-C - Providers', 'description': 'Collapsed across Standard and Adapted TranS-C.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '4.95', 'spread': '0.11', 'groupId': 'OG000'}, {'value': '4.59', 'spread': '0.57', 'groupId': 'OG001'}, {'value': '4.64', 'spread': '0.54', 'groupId': 'OG002'}]}]}, {'title': 'Mid-treatment', 'categories': [{'measurements': [{'value': '4.83', 'spread': '0.29', 'groupId': 'OG000'}, {'value': '4.60', 'spread': '0.54', 'groupId': 'OG001'}, {'value': '4.61', 'spread': '0.53', 'groupId': 'OG002'}]}]}, {'title': 'Post-treatment', 'categories': [{'measurements': [{'value': '4.44', 'spread': '0.72', 'groupId': 'OG000'}, {'value': '4.42', 'spread': '0.65', 'groupId': 'OG001'}, {'value': '4.43', 'spread': '0.65', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, mid-treatment (2 weeks post-baseline for Adapted TranS-C and 4 weeks post-baseline for Standard TranS-C), post-treatment (4 weeks post-baseline for Adapted TranS-C and 8 weeks post-baseline for Standard TranS-C).', 'description': 'Assesses provider perceptions of the feasibility of the treatment intervention using a self-report questionnaire. The 4- item scale is rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). A total score is calculated by averaging all four items. Total scores range from 1 to 5, with higher scores indicating greater perceptions of feasibility.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Feasibility of Intervention Measure was collected only from providers. To increase the sample size, and because providers treated patients who could have been in either the immediate or UC-DT conditions, we analyzed by collapsing across immediate and UC-DT for providers. For some analyses, data were collapsed across Standard and Adapted TranS-C. This measure was not assessed following usual care.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Midpoint of Sleep Measure', 'timeFrame': 'Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment, to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses circadian functioning by calculating the midpoint between falling asleep time and rise time.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Alcohol Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day quantity and frequency of alcohol intake using a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Substances Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day frequency of substance use using a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Tobacco Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day quantity and frequency of tobacco intake using a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Caffeine Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day quantity and frequency of caffeine intake using a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Suicidal Ideation Questionnaire', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day suicidal ideation using a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Credibility Expectancy Questionnaire', 'timeFrame': 'Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.', 'description': 'Measures the credibility and expectation of improvement from TranS-C. The questionnaire includes 4 items.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Utilization Questionnaire', 'timeFrame': 'Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.', 'description': 'Measures the elements of TranS-C that are most used.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Utilization Questionnaire', 'timeFrame': 'Once at 6-month follow-up after treatment ends.', 'description': 'Measures the elements of TranS-C that are most used.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Duke Checklist of Medical Conditions & Symptoms', 'timeFrame': 'Once at baseline.', 'description': 'Assesses physical illness or neurological degenerative disease directly related to the onset and course of the sleep and circadian dysfunction.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Checklist of Modules Delivered', 'timeFrame': 'Once at each session between patient and provider.', 'description': 'Assesses which treatment modules were delivered by the providers using a self-report checklist.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Adaptations to Evidence-Based Practices Scale', 'timeFrame': 'Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.', 'description': 'Assesses ad hoc modifications the provider made to the treatment using a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Use of TranS-C Assessment', 'timeFrame': 'Once during the 1 year sustainment phase.', 'description': 'Assesses if providers continue to use TranS-C in a self-report questionnaire.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Session Attendance and Duration Log', 'timeFrame': 'Once at each session between patient and provider.', 'description': 'Collect session date and duration (length of session).', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Training Evaluation/Knowledge Test', 'timeFrame': 'Through the first 2.5 years of the study, an average of 4 per month', 'description': 'Provider evaluation of the training; provider knowledge of content covered in the training; provider willingness and confidence in delivering TranS-C.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Gold Standard Training Elements', 'timeFrame': 'Through the first 2.5 years of the study, an average of 4 per month', 'description': 'Extent of gold standard training elements present in each training session, with respect to content and technique.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Number of TranS-C Sessions', 'timeFrame': 'Once per patient at posttreatment, which is 6 or 10 weeks after the beginning of treatment', 'description': 'Number of sessions delivered to each enrolled patient by each provider.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Facilitator-level Outcome: Implementation Log', 'timeFrame': 'Up to 30 months', 'description': 'Weekly record of facilitator activities, amount of time per activity, county, year, type of communication, implementation strategies, target(s), intended outcome(s).', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Facilitator-level Outcome: Meeting Log', 'timeFrame': 'Up to 30 months', 'description': 'Weekly record of community meeting details as applicable, including: county, generation, level of contact (i.e., leadership, providers), type/modality of contact, length of meeting, number of attendees, recording, general description, standardized description, main presenter and role of UC Berkeley staff.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance', 'timeFrame': 'Change from baseline to mid-treatment, which is 2 or 4 weeks after the beginning of treatment', 'description': 'Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Provider-level Outcome: Acceptability Intervention Measure', 'timeFrame': 'Change from baseline to mid-treatment, which is 2 or 4 weeks after the beginning of treatment for each client', 'description': 'Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire and provider feedback.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Standard TranS-C', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.'}, {'id': 'FG001', 'title': 'Adapted TranS-C', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the Community Mental Health Center (CMHC) context.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numUnits': '3', 'numSubjects': '22'}, {'groupId': 'FG001', 'numUnits': '5', 'numSubjects': '174'}]}, {'type': 'Providers', 'comment': 'Providers treated patients who were in both immediate TranS-C and delayed TranS-C conditions. To increase the sample for generation 2 providers, data for all providers were analyzed (combining across UC-DT and immediate patients that they treated).', 'achievements': [{'groupId': 'FG000', 'numUnits': '3', 'numSubjects': '6'}, {'groupId': 'FG001', 'numUnits': '5', 'numSubjects': '47'}]}, {'type': 'Patients - Immediate', 'achievements': [{'groupId': 'FG000', 'numUnits': '3', 'numSubjects': '8'}, {'groupId': 'FG001', 'numUnits': '5', 'numSubjects': '70'}]}, {'type': 'Patients - UC-DT', 'comment': '6-month follow up was collected for immediate TranS-C only. Following usual care (UC) participants in the Adapted TranS-C condition started TranS-C 4 weeks after UC, and participants in the Standard TranS-C condition started TranS-C 8 weeks after UC.', 'achievements': [{'groupId': 'FG000', 'numUnits': '3', 'numSubjects': '8'}, {'groupId': 'FG001', 'numUnits': '5', 'numSubjects': '57'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numUnits': '3', 'numSubjects': '10'}, {'groupId': 'FG001', 'numUnits': '5', 'numSubjects': '110'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numUnits': '0', 'numSubjects': '12'}, {'groupId': 'FG001', 'numUnits': '0', 'numSubjects': '64'}]}], 'dropWithdraws': [{'type': 'Patients lost to post or 6-month follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '12'}, {'groupId': 'FG001', 'numSubjects': '64'}]}]}], 'typeUnitsAnalyzed': 'CMHC Sites', 'preAssignmentDetails': 'CMHCs (the units) were randomized to "Standard TranS-C" or "Adapted TranS-C" but CMHCs were not further randomized to UC-DT or Immediate TranS-C. Patients within a CMHC were randomized to UC-DT or immediate TranS-C. Therefore, only "Standard TranS-C" and "Adapted TranS-C" are reported in the participant flow so that units (i.e., CMHCS) are not counted more than once across a row.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '196', 'groupId': 'BG006'}]}], 'groups': [{'id': 'BG000', 'title': 'Standard TranS-C (Immediate)', 'description': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.\n\nStandard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nParticipants in this group received Standard TranS-C immediately.'}, {'id': 'BG001', 'title': 'Adapted TranS-C (Immediate)', 'description': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.\n\nThe process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nParticipants in this group received Adapted TranS-C immediately.'}, {'id': 'BG002', 'title': 'Standard TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Standard TranS-C.'}, {'id': 'BG003', 'title': 'Adapted TranS-C (UC-DT)', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).\n\nParticipants in this group received usual care followed by delayed treatment with Adapted TranS-C.'}, {'id': 'BG004', 'title': 'Standard TranS-C - Providers', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.\n\nThese data reflect the characteristics of providers who delivered Standard TranS-C.'}, {'id': 'BG005', 'title': 'Adapted TranS-C - Providers', 'description': 'The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.\n\nThese data reflect the characteristics of providers who delivered Adapted TranS-C.'}, {'id': 'BG006', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '43.75', 'spread': '13.18', 'groupId': 'BG000'}, {'value': '43.26', 'spread': '15.35', 'groupId': 'BG001'}, {'value': '46.25', 'spread': '8.21', 'groupId': 'BG002'}, {'value': '43.43', 'spread': '14.43', 'groupId': 'BG003'}, {'value': '43.52', 'spread': '13.72', 'groupId': 'BG006'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'Years', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Age for patients'}, {'title': 'Age, Continuous', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '39.50', 'spread': '12.40', 'groupId': 'BG004'}, {'value': '40.21', 'spread': '10.19', 'groupId': 'BG005'}, {'value': '40.13', 'spread': '10.33', 'groupId': 'BG006'}]}]}], 'paramType': 'MEAN', 'description': 'Age for providers.', 'unitOfMeasure': 'Years', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}, {'title': 'Sex/Gender, Customized', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '196', 'groupId': 'BG006'}]}], 'categories': [{'title': 'Female', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '42', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '39', 'groupId': 'BG003'}, {'value': '5', 'groupId': 'BG004'}, {'value': '33', 'groupId': 'BG005'}, {'value': '128', 'groupId': 'BG006'}]}, {'title': 'Male', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '28', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '18', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '2', 'groupId': 'BG005'}, {'value': '55', 'groupId': 'BG006'}]}, {'title': 'Missing/declined to answer', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '12', 'groupId': 'BG005'}, {'value': '13', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '196', 'groupId': 'BG006'}]}], 'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '18', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '8', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '8', 'groupId': 'BG005'}, {'value': '40', 'groupId': 'BG006'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '52', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '49', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '25', 'groupId': 'BG005'}, {'value': '140', 'groupId': 'BG006'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '14', 'groupId': 'BG005'}, {'value': '16', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '196', 'groupId': 'BG006'}]}], 'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '7', 'groupId': 'BG006'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '7', 'groupId': 'BG005'}, {'value': '11', 'groupId': 'BG006'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '15', 'groupId': 'BG006'}]}, {'title': 'Black or African American', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '12', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '12', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '32', 'groupId': 'BG006'}]}, {'title': 'White', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '32', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '22', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '24', 'groupId': 'BG005'}, {'value': '83', 'groupId': 'BG006'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '12', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '8', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '23', 'groupId': 'BG006'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '14', 'groupId': 'BG005'}, {'value': '25', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'United States', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '196', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '196', 'groupId': 'BG006'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'Education', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'title': 'High school graduate or below', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '5', 'groupId': 'BG003'}, {'value': '14', 'groupId': 'BG006'}]}, {'title': 'Some or completed college or vocational school', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '45', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '34', 'groupId': 'BG003'}, {'value': '87', 'groupId': 'BG006'}]}, {'title': 'Some or completed graduate school', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '17', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '17', 'groupId': 'BG003'}, {'value': '38', 'groupId': 'BG006'}]}, {'title': 'Other/ category not listed', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG006'}]}, {'title': 'Missing/ declined to answer', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Employment', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'title': 'Full-time', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '13', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '11', 'groupId': 'BG003'}, {'value': '28', 'groupId': 'BG006'}]}, {'title': 'Part-time', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '10', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '9', 'groupId': 'BG003'}, {'value': '22', 'groupId': 'BG006'}]}, {'title': 'Not employed', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '45', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '34', 'groupId': 'BG003'}, {'value': '86', 'groupId': 'BG006'}]}, {'title': 'Other/ category not listed', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '7', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Civil Status', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'title': 'Partnered', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '16', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '9', 'groupId': 'BG003'}, {'value': '28', 'groupId': 'BG006'}]}, {'title': 'Unpartnered', 'measurements': [{'value': '7', 'groupId': 'BG000'}, {'value': '54', 'groupId': 'BG001'}, {'value': '5', 'groupId': 'BG002'}, {'value': '47', 'groupId': 'BG003'}, {'value': '113', 'groupId': 'BG006'}]}, {'title': 'Other/ category not listed', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG006'}]}, {'title': 'Missing/ declined to answer', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Living Arrangement', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'title': 'Alone', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '11', 'groupId': 'BG003'}, {'value': '27', 'groupId': 'BG006'}]}, {'title': 'With family', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '38', 'groupId': 'BG001'}, {'value': '7', 'groupId': 'BG002'}, {'value': '31', 'groupId': 'BG003'}, {'value': '81', 'groupId': 'BG006'}]}, {'title': 'With friend or roommate or With friend or roommate or pet', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '13', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '22', 'groupId': 'BG006'}]}, {'title': 'Supportive housing', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '6', 'groupId': 'BG003'}, {'value': '10', 'groupId': 'BG006'}]}, {'title': 'Other/ category not listed', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG006'}]}, {'title': 'Missing/ declined to answer', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Government Assistance', 'classes': [{'title': 'Unemployment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG006'}]}]}, {'title': 'Medicare', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '12', 'groupId': 'BG006'}]}]}, {'title': 'Medicaid', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '26', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '20', 'groupId': 'BG003'}, {'value': '50', 'groupId': 'BG006'}]}]}, {'title': 'Social Security', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '16', 'groupId': 'BG006'}]}]}, {'title': 'Food Stamps', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '13', 'groupId': 'BG003'}, {'value': '30', 'groupId': 'BG006'}]}]}, {'title': 'Supplemental Security Income/ Social Security Disability Insurance', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '27', 'groupId': 'BG006'}]}]}, {'title': 'Supplemental Nutrition Assistance Program', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '6', 'groupId': 'BG003'}, {'value': '15', 'groupId': 'BG006'}]}]}, {'title': 'Other/category not listed', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '10', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '21', 'groupId': 'BG006'}]}]}, {'title': 'Missing/declined to answer', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '21', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '17', 'groupId': 'BG003'}, {'value': '43', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Some patients endorsed more than one government assistance category.', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Annual Household Income', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'title': '<$10,000', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '7', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '13', 'groupId': 'BG003'}, {'value': '21', 'groupId': 'BG006'}]}, {'title': '$10,000-$20,000', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '9', 'groupId': 'BG003'}, {'value': '27', 'groupId': 'BG006'}]}, {'title': '$20,000-$30,000', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '15', 'groupId': 'BG006'}]}, {'title': '$30,000-$40,000', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '7', 'groupId': 'BG006'}]}, {'title': '$40,000-$50,000', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '7', 'groupId': 'BG006'}]}, {'title': '>= $50,000', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '17', 'groupId': 'BG003'}, {'value': '32', 'groupId': 'BG006'}]}, {'title': "I don't know my income", 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '18', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '11', 'groupId': 'BG003'}, {'value': '32', 'groupId': 'BG006'}]}, {'title': 'Missing/ declined to answer', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Self-reported Diagnosis', 'classes': [{'title': 'Neurodevelopmental disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '10', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '11', 'groupId': 'BG003'}, {'value': '22', 'groupId': 'BG006'}]}]}, {'title': 'Psychosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '20', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '13', 'groupId': 'BG003'}, {'value': '36', 'groupId': 'BG006'}]}]}, {'title': 'Bipolar Disorder', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '8', 'groupId': 'BG003'}, {'value': '25', 'groupId': 'BG006'}]}]}, {'title': 'Major Depressive Disorder', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '31', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '28', 'groupId': 'BG003'}, {'value': '66', 'groupId': 'BG006'}]}]}, {'title': 'Anxiety disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '30', 'groupId': 'BG001'}, {'value': '5', 'groupId': 'BG002'}, {'value': '34', 'groupId': 'BG003'}, {'value': '72', 'groupId': 'BG006'}]}]}, {'title': 'Obsessive- compulsive and related disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '5', 'groupId': 'BG006'}]}]}, {'title': 'Trauma and stressor-related disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '17', 'groupId': 'BG003'}, {'value': '33', 'groupId': 'BG006'}]}]}, {'title': 'Dissociative disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG006'}]}]}, {'title': 'Personality disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG006'}]}]}, {'title': 'Feeding and eating disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG006'}]}]}, {'title': 'Substance-related and addictive disorders', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '5', 'groupId': 'BG006'}]}]}, {'title': 'Other/category not listed', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG006'}]}]}, {'title': 'Missing/declined to answer', 'denoms': [{'units': 'Participants', 'counts': [{'value': '8', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '143', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '7', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '15', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Some patients endorsed more than one self-reported diagnosis.', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from providers.'}, {'title': 'Degree Type', 'classes': [{'title': 'Marriage and Family Therapy', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '4', 'groupId': 'BG006'}]}]}, {'title': 'Psychology', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '5', 'groupId': 'BG006'}]}]}, {'title': 'Social Work', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '4', 'groupId': 'BG004'}, {'value': '15', 'groupId': 'BG005'}, {'value': '19', 'groupId': 'BG006'}]}]}, {'title': 'Nursing', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG004'}, {'value': '8', 'groupId': 'BG005'}, {'value': '8', 'groupId': 'BG006'}]}]}, {'title': 'Medical', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}]}]}, {'title': 'Other/category not listed', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '4', 'groupId': 'BG006'}]}]}, {'title': 'Missing/declined to answer', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG004'}, {'value': '12', 'groupId': 'BG005'}, {'value': '13', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Some providers endorsed more than one degree type.', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}, {'title': 'Therapeutic Approach', 'classes': [{'title': 'Client Centered', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '5', 'groupId': 'BG004'}, {'value': '29', 'groupId': 'BG005'}, {'value': '34', 'groupId': 'BG006'}]}]}, {'title': 'Family Systems', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG004'}, {'value': '8', 'groupId': 'BG005'}, {'value': '8', 'groupId': 'BG006'}]}]}, {'title': 'Cognitive Behavioral Therapy', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG004'}, {'value': '20', 'groupId': 'BG005'}, {'value': '22', 'groupId': 'BG006'}]}]}, {'title': 'Psychodynamic', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG004'}, {'value': '11', 'groupId': 'BG005'}, {'value': '12', 'groupId': 'BG006'}]}]}, {'title': 'Humanistic', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG004'}, {'value': '7', 'groupId': 'BG005'}, {'value': '8', 'groupId': 'BG006'}]}]}, {'title': 'Integrative/Holistic', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG004'}, {'value': '2', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}]}]}, {'title': 'Missing/declined to answer', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG004'}, {'value': '13', 'groupId': 'BG005'}, {'value': '14', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Some providers endorsed more than one therapeutic approach.', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}, {'title': 'Licensure', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'title': 'Licensed', 'measurements': [{'value': '3', 'groupId': 'BG004'}, {'value': '24', 'groupId': 'BG005'}, {'value': '27', 'groupId': 'BG006'}]}, {'title': 'Not Licensed', 'measurements': [{'value': '2', 'groupId': 'BG004'}, {'value': '11', 'groupId': 'BG005'}, {'value': '13', 'groupId': 'BG006'}]}, {'title': 'Missing/ declined to answer', 'measurements': [{'value': '1', 'groupId': 'BG004'}, {'value': '12', 'groupId': 'BG005'}, {'value': '13', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}, {'title': 'Caseload', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '33.00', 'spread': '37.24', 'groupId': 'BG004'}, {'value': '33.29', 'spread': '40.18', 'groupId': 'BG005'}, {'value': '33.26', 'spread': '39.17', 'groupId': 'BG006'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'Number of patients', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}, {'title': 'Employment Duration', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '1.20', 'spread': '1.10', 'groupId': 'BG004'}, {'value': '5.41', 'spread': '6.23', 'groupId': 'BG005'}, {'value': '4.86', 'spread': '5.98', 'groupId': 'BG006'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'Years', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}, {'title': 'Years Since Degree Earned', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '47', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}]}], 'categories': [{'measurements': [{'value': '6.40', 'spread': '6.43', 'groupId': 'BG004'}, {'value': '9.63', 'spread': '9.69', 'groupId': 'BG005'}, {'value': '9.26', 'spread': '9.39', 'groupId': 'BG006'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'Years', 'dispersionType': 'STANDARD_DEVIATION', 'populationDescription': 'Data not collected for this Baseline Measure from patients.'}], 'populationDescription': 'Providers treated patients who were in both immediate TranS-C and delayed TranS-C conditions. To increase the sample for generation 2 providers, data for all providers were analyzed (combining across UC-DT and immediate patients that they treated'}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2024-07-29', 'size': 575523, 'label': 'Study Protocol and Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'Prot_SAP_000.pdf', 'typeAbbrev': 'Prot_SAP', 'uploadDate': '2025-08-15T00:01', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR'], 'maskingDescription': 'The assessment team will be blind to group allocation at post-treatment and six-month follow-up'}, 'primaryPurpose': 'HEALTH_SERVICES_RESEARCH', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'CMHC sites will be cluster randomized to either Standard TranS-C or Adapted TranS-C. Then within each CMHC site, patients will be randomized to either TranS-C or to Usual Care followed by Delayed Treatment (UC-DT).'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 196}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2020-12-14', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-10', 'completionDateStruct': {'date': '2024-05-08', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2025-10-07', 'studyFirstSubmitDate': '2023-03-10', 'resultsFirstSubmitDate': '2025-08-20', 'studyFirstSubmitQcDate': '2023-03-27', 'lastUpdatePostDateStruct': {'date': '2025-10-23', 'type': 'ESTIMATED'}, 'resultsFirstSubmitQcDate': '2025-10-07', 'studyFirstPostDateStruct': {'date': '2023-04-10', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2025-10-23', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2024-05-08', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Patient-level Outcome: Midpoint of Sleep Measure', 'timeFrame': 'Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment, to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses circadian functioning by calculating the midpoint between falling asleep time and rise time.'}, {'measure': 'Patient-level Outcome: Alcohol Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day quantity and frequency of alcohol intake using a self-report questionnaire.'}, {'measure': 'Patient-level Outcome: Substances Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day frequency of substance use using a self-report questionnaire.'}, {'measure': 'Patient-level Outcome: Tobacco Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day quantity and frequency of tobacco intake using a self-report questionnaire.'}, {'measure': 'Patient-level Outcome: Caffeine Intake', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day quantity and frequency of caffeine intake using a self-report questionnaire.'}, {'measure': 'Patient-level Outcome: Suicidal Ideation Questionnaire', 'timeFrame': 'Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.', 'description': 'Assesses past 30-day suicidal ideation using a self-report questionnaire.'}, {'measure': 'Patient-level Outcome: Credibility Expectancy Questionnaire', 'timeFrame': 'Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.', 'description': 'Measures the credibility and expectation of improvement from TranS-C. The questionnaire includes 4 items.'}, {'measure': 'Patient-level Outcome: Utilization Questionnaire', 'timeFrame': 'Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.', 'description': 'Measures the elements of TranS-C that are most used.'}, {'measure': 'Patient-level Outcome: Utilization Questionnaire', 'timeFrame': 'Once at 6-month follow-up after treatment ends.', 'description': 'Measures the elements of TranS-C that are most used.'}, {'measure': 'Patient-level Outcome: Duke Checklist of Medical Conditions & Symptoms', 'timeFrame': 'Once at baseline.', 'description': 'Assesses physical illness or neurological degenerative disease directly related to the onset and course of the sleep and circadian dysfunction.'}, {'measure': 'Provider-level Outcome: Checklist of Modules Delivered', 'timeFrame': 'Once at each session between patient and provider.', 'description': 'Assesses which treatment modules were delivered by the providers using a self-report checklist.'}, {'measure': 'Provider-level Outcome: Adaptations to Evidence-Based Practices Scale', 'timeFrame': 'Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.', 'description': 'Assesses ad hoc modifications the provider made to the treatment using a self-report questionnaire.'}, {'measure': 'Provider-level Outcome: Use of TranS-C Assessment', 'timeFrame': 'Once during the 1 year sustainment phase.', 'description': 'Assesses if providers continue to use TranS-C in a self-report questionnaire.'}, {'measure': 'Provider-level Outcome: Session Attendance and Duration Log', 'timeFrame': 'Once at each session between patient and provider.', 'description': 'Collect session date and duration (length of session).'}, {'measure': 'Provider-level Outcome: Training Evaluation/Knowledge Test', 'timeFrame': 'Through the first 2.5 years of the study, an average of 4 per month', 'description': 'Provider evaluation of the training; provider knowledge of content covered in the training; provider willingness and confidence in delivering TranS-C.'}, {'measure': 'Provider-level Outcome: Gold Standard Training Elements', 'timeFrame': 'Through the first 2.5 years of the study, an average of 4 per month', 'description': 'Extent of gold standard training elements present in each training session, with respect to content and technique.'}, {'measure': 'Provider-level Outcome: Number of TranS-C Sessions', 'timeFrame': 'Once per patient at posttreatment, which is 6 or 10 weeks after the beginning of treatment', 'description': 'Number of sessions delivered to each enrolled patient by each provider.'}, {'measure': 'Facilitator-level Outcome: Implementation Log', 'timeFrame': 'Up to 30 months', 'description': 'Weekly record of facilitator activities, amount of time per activity, county, year, type of communication, implementation strategies, target(s), intended outcome(s).'}, {'measure': 'Facilitator-level Outcome: Meeting Log', 'timeFrame': 'Up to 30 months', 'description': 'Weekly record of community meeting details as applicable, including: county, generation, level of contact (i.e., leadership, providers), type/modality of contact, length of meeting, number of attendees, recording, general description, standardized description, main presenter and role of UC Berkeley staff.'}, {'measure': 'Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance', 'timeFrame': 'Change from baseline to mid-treatment, which is 2 or 4 weeks after the beginning of treatment', 'description': 'Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).'}, {'measure': 'Provider-level Outcome: Acceptability Intervention Measure', 'timeFrame': 'Change from baseline to mid-treatment, which is 2 or 4 weeks after the beginning of treatment for each client', 'description': 'Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire and provider feedback.'}], 'primaryOutcomes': [{'measure': 'Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep DisturbanceMeasurement Information System - Sleep Disturbance', 'timeFrame': 'Baseline, mid-treatment (2/4 weeks post-baseline), post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Scale. The 8-item short version scale assesses perceived sleep problems (e.g., sleep quality, perception of sleep difficulties) over a 7-day period. Items are rated on a 5-point scale ranging from 1 (not at all) to 5 (very much). Raw scores are summed to produce a single score, resulting in a range from 8 to 40. Raw scores are converted to t-scores using treatment manuals. T-scores range from 30.5 to 77.5. A T-score of 50 indicates the population mean with a standard deviation of 10. Higher scores indicate worse sleep disturbance.'}, {'measure': 'Provider-level Outcome: Acceptability Intervention Measure', 'timeFrame': 'Baseline, mid-treatment (2 weeks post-baseline for Adapted TranS-C and 4 weeks post-baseline for Standard TranS- C), post-treatment (4 weeks post-baseline for Adapted TranS-C and 8 weeks post-baseline for Standard TranS-C).', 'description': 'Assesses provider perceptions of the acceptability of the treatment intervention using a self-report questionnaire. The 4-item scale is rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). A total score is calculated by averaging all four items. Total scores range from 1 to 5, with higher scores indicating greater perceptions of acceptability.'}], 'secondaryOutcomes': [{'measure': 'Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment', 'timeFrame': 'Baseline, mid-treatment (2/4 weeks post-baseline), post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Impairment Scale. The 8-item short version scale assesses perceived sleep problems during waking hours (e.g., alertness, sleepiness, tiredness) over a 7-day period. Items are rated on a 5-point scale ranging from 1 (not at all) to 5 (very much). Raw scores are summed to produce a single score, resulting in a range from 8 to 40. Raw scores are converted to t-scores using treatment manuals. T-scores range from 30.1 to 80.1. A T-score of 50 indicates the population mean with a standard deviation of 10. Higher scores indicate worse sleep-related impairment.'}, {'measure': 'Patient-level Outcome: Composite Sleep Health Score', 'timeFrame': 'Baseline, mid-treatment (2/4 weeks post-baseline), post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'Composite Sleep Health Score is defined as the sum of scores on 6 sleep health dimensions: Regularity (Midpoint sleep fluctuation across a 7-day sleep diary \\< 1 hour), Satisfaction (Sleep quality question on PROMIS-Sleep Disturbance (PROMIS = Patient-Reported Outcomes Measurement Information System)), Alertness (Daytime sleepiness question on PROMIS-Sleep Related Impairment (PROMIS = Patient-Reported Outcomes Measurement Information System)), Timing (Mean midpoint sleep across the 7 day sleep diary between 2 and 4 AM), Efficiency (Average sleep efficiency based on the 7 day sleep diary ≥ 85%), and Duration (Total Sleep Time average based on 7 day sleep diary between 7 and 9 hours). Each dimension was dichotomized such that 1 = good /yes; 0 = poor/no). Total composite sleep health score ranges from 0 to 6, with larger values indicating better sleep health.'}, {'measure': 'Patient-level Outcome: Sheehan Disability Scale', 'timeFrame': 'Baseline, post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'The Sheehan Disability Scale (SDS) assesses impairment in work/school, social, and family life. Items are rated on a scale from 0 (not at all) to 10 (extremely). Items are summed to produce a single score. Scores range from 0 to 30, with higher scores indicating higher functional impairment.'}, {'measure': 'Patient-level Outcome: The Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure', 'timeFrame': 'Baseline, post-treatment (4/8 weeks post-baseline - the UC-DT post-assessment follows the same timeframe post-usual care and delayed treatment) for Adapted/Standard TranS-C, respectively, and 6-month follow-up.', 'description': 'The Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure (DSM-5) assesses psychiatric symptoms across 13 mental health domains. Participants rate on a 5-point scale how often they were bothered by each symptom on a scale from 0 (not at all) to 4 (nearly every day). Scores range from 0 to 52, with higher scores indicating more severe symptoms.'}, {'measure': 'Provider-level Outcome: Intervention Appropriateness Measure', 'timeFrame': 'Baseline, mid-treatment (2 weeks post-baseline for Adapted TranS-C and 4 weeks post-baseline for Standard TranS- C), post-treatment (4 weeks post-baseline for Adapted TranS-C and 8 weeks post-baseline for Standard TranS-C).', 'description': 'Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire. The 4-item scale is rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). A total score is calculated by averaging all four items. Total scores range from 1 to 5, with higher scores indicating greater perceptions of appropriateness.'}, {'measure': 'Provider-level Outcome: Feasibility of Intervention Measure', 'timeFrame': 'Baseline, mid-treatment (2 weeks post-baseline for Adapted TranS-C and 4 weeks post-baseline for Standard TranS-C), post-treatment (4 weeks post-baseline for Adapted TranS-C and 8 weeks post-baseline for Standard TranS-C).', 'description': 'Assesses provider perceptions of the feasibility of the treatment intervention using a self-report questionnaire. The 4- item scale is rated on a 5-point scale from 1 (completely disagree) to 5 (completely agree). A total score is calculated by averaging all four items. Total scores range from 1 to 5, with higher scores indicating greater perceptions of feasibility.'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Sleep Disorder', 'Circadian Dysregulation']}, 'referencesModule': {'references': [{'pmid': '41318500', 'type': 'DERIVED', 'citation': 'Harvey AG, Agnew ER, Esteva Hache R, Callaway CA, Ovalle Patino E, Milner A, Spencer JM, Diaz M, Dong L, Kilbourne AM, Buysse DJ, Stice E, Sarfan LD. A randomized trial of adapted versus standard versions the transdiagnostic intervention for sleep and circadian dysfunction (TSC) implemented via facilitation and delivered by community mental health providers using train-the-trainer. Implement Sci. 2025 Nov 29. doi: 10.1186/s13012-025-01467-y. Online ahead of print.'}, {'pmid': '40799745', 'type': 'DERIVED', 'citation': 'Horwitz TB, Sarfan LD, Milner AE, Varghese J, Callaway CA, Harvey AG. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TSC) in Community Mental Health: Evaluating Self-Reported Psychiatric Disorders as a Predictor of Symptoms and Treatment Outcome. Res Sq [Preprint]. 2025 Aug 6:rs.3.rs-7189279. doi: 10.21203/rs.3.rs-7189279/v1.'}, {'pmid': '40709255', 'type': 'DERIVED', 'citation': 'Harvey A, Agnew ER, Hache RE, Callaway CA, Patino EO, Milner A, Spencer JM, Diaz M, Dong L, Kilbourne AM, Buysse DJ, Stice E, Sarfan LD. A randomized trial of Adapted versus Standard versions the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TSC) implemented via facilitation and delivered by community mental health providers using train-the-trainer. Res Sq [Preprint]. 2025 Jul 14:rs.3.rs-6414484. doi: 10.21203/rs.3.rs-6414484/v1.'}, {'pmid': '37550730', 'type': 'DERIVED', 'citation': 'Callaway CA, Sarfan LD, Agnew ER, Dong L, Spencer JM, Hache RE, Diaz M, Howlett SA, Fisher KR, Yates HEH, Stice E, Kilbourne AM, Buysse DJ, Harvey AG. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 2: study protocol for a hybrid type 2 effectiveness-implementation cluster-randomized trial using train-the-trainer. Trials. 2023 Aug 7;24(1):503. doi: 10.1186/s13063-023-07523-6.'}, {'pmid': '37398014', 'type': 'DERIVED', 'citation': 'Callaway CA, Sarfan LD, Agnew ER, Dong L, Spencer JM, Hache RE, Diaz M, Howlett SA, Fisher KR, Yates HEH, Stice E, Kilbourne AM, Buysse DJ, Harvey AG. The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 2: Study protocol for a hybrid type 2 effectiveness-implementation cluster- randomized trial using train-the-trainer. Res Sq [Preprint]. 2023 Jun 17:rs.3.rs-2943787. doi: 10.21203/rs.3.rs-2943787/v1.'}]}, 'descriptionModule': {'briefSummary': 'The train-the-trainer (TTT) approach is a promising method of sustaining training efforts in community mental health centers (CMHCs). This study will test the implementation and effectiveness outcomes of a sleep treatment delivered by CMHC providers who are trained and supervised within CMHCs via TTT. The investigators will test two versions of the sleep treatment, a "Standard" version and an "Adapted" version that has been adapted using theory, data and stakeholder inputs to improve the fit for SMI patients treated in community mental health centers.', 'detailedDescription': 'There are significant barriers to widespread implementation and sustainment of evidence-based psychological treatments (EBPTs) in community mental health centers (CMHCs), including insufficient time and funding, shortage of trainers and consultants, and staff turnover. The investigators propose to evaluate one possible solution, the train-the-trainer (TTT) approach, in the context of a transdiagnostic EBPT for sleep and circadian dysfunction-the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)- for serious mental illness (SMI) in CMHCs. This entry describes the Train-the-Trainer Phase, the second of a three-phase hybrid type 2 effectiveness-implementation trial conducted to test TranS-C in CMHCs.\n\nTTT is a training structure with multiple levels, called "Generations." First, external expert trainers train an initial cohort of providers in a specific EBPT ("Generation 1 providers"). Next, Generation 1 providers are offered additional training in how to train others in the EBPT and become "local trainers." These local trainers then train the next cohort of providers within their organization ("Generation 2 providers").\n\nThe Train-the-Trainer Phase builds upon the first phase, the Implementation Phase (NCT04154631), in which implementation and effectiveness outcomes of two versions of TranS-C, Standard and Adapted are compared, with CMHC providers, who are trained by treatment experts. Adapted TranS-C is a version of TranS-C designed to improve \'fit\' with the CMHC context. In the Train-the-Trainer Phase, the aim is to test implementation and effectiveness outcomes of Standard and Adapted TranS-C with CMHC providers who are trained and supervised within CMHCs (i.e., Generation 2 of TTT).\n\nIn the Implementation Phase, 10 CMHC clinic sites were cluster randomized to either Standard or Adapted TranS-C. Nine CMHCs continued participation into the Train-the-Trainer Phase. Within each CMHC site, patients are randomized to immediate TranS-C or to Usual Care followed by Delayed Treatment (UC-DT). Generation 2 patients (n=130) will be assessed pre, mid and post-treatment and at 6 month follow-up. UC Berkeley will coordinate the research, facilitate implementation, collect data, etc. Generation 2 providers (n=60), trained by local trainers within an established network of CMHCs, will implement TranS-C and will be assessed at pre and post-treatment. SA1 is to confirm that both Standard vs. Adapted TranS-C, compared to UC-DT, improve sleep and circadian functioning and reduce functional impairment and disorder-focused psychiatric symptoms for Generation 2 patients. SA2 is to evaluate the fit, to the CMHC context, of Standard vs. Adapted TranS-C via Generation 2 provider ratings of acceptability, appropriateness and feasibility. SA3 will examine if better fit, operationalized via Generation 2 provider ratings of acceptability, mediates the relationship between treatment condition and Generation 2 patient outcome. This research will determine if (1) sleep and circadian problems can be effectively addressed in SMI by CMHC providers trained and supervised within CMHCs via the train-the-trainer approach, (2) test two variations of TranS-C that each have unique advantages and focus on community providers and typical community patients.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\nThe inclusion criteria for the CMHC local trainers are:\n\n* Employed in participating CMHCs\n* Completed a Generation 1 TranS-C training (i.e., led by UC Berkeley expert trainers)\n* Volunteer to participate and formally consent to participate\n\nThe inclusion criteria for CMHCs are:\n\n* Publicly funded adult mental health outpatient services\n* Support from CMHC leadership\n\nThe inclusion criteria for CMHC providers are:\n\n* Employed or able to deliver client-facing services to CMHC clients\n* Interest in learning and delivering TranS-C\n* Volunteer to participate and formally consent to participate\n\nConsumers must meet the following inclusion criteria:\n\n* Aged 18 years and older\n* Meet criteria for an SMI per self-report and confirmed by referring provider or administration of the Mini International Neuropsychiatric Interview (MINI) (DSM-5, Version 7.0.0) by a licensed clinical social worker on the research team\n* Exhibit a sleep or circadian disturbance as determined by endorsing 4 "quite a bit" or 5 "very much" (or the equivalent for reverse scored items) on one or more PROMIS-SD questions\n* Receiving the standard of care for the SMI and consent to regular communications between the research team and provider\n* Consent to access their medical record and participate in assessments\n* Guaranteed place to sleep for at least 2 months that is not a shelter\n\nExclusion Criteria:\n\n* Presence of an active and progressive physical illness or neurological degenerative disease directly related to the onset and course of the sleep and circadian dysfunction, or making participation in the study unfeasible based on confirmation from the treating clinician and/or medical record\n* Presence of substance abuse/dependence only if it makes participation in the study unfeasible\n* Current active intent or plan to commit suicide (those with suicidal ideation are eligible) only if it makes participation in the study unfeasible, or homicide risk\n* Night shift work \\>2 nights per week in the past 3 months\n* Pregnancy or breast-feeding'}, 'identificationModule': {'nctId': 'NCT05805657', 'briefTitle': 'Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer', 'organization': {'class': 'OTHER', 'fullName': 'University of California, Berkeley'}, 'officialTitle': 'Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment to Improve Severe Mental Illness Outcomes in Community Mental Health Part 2: Train-the-Trainer', 'orgStudyIdInfo': {'id': 'R01MH120147_P2'}, 'secondaryIdInfos': [{'id': 'R01MH120147', 'link': 'https://reporter.nih.gov/quickSearch/R01MH120147', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Standard TranS-C', 'description': 'Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.', 'interventionNames': ['Behavioral: Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)']}, {'type': 'EXPERIMENTAL', 'label': 'Adapted TranS-C', 'description': 'The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.', 'interventionNames': ['Behavioral: Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'UC-DT', 'description': 'Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).', 'interventionNames': ['Other: Usual Care Delayed Treatment']}], 'interventions': [{'name': 'Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)', 'type': 'BEHAVIORAL', 'description': 'TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.', 'armGroupLabels': ['Standard TranS-C']}, {'name': 'Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)', 'type': 'BEHAVIORAL', 'description': 'The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.', 'armGroupLabels': ['Adapted TranS-C']}, {'name': 'Usual Care Delayed Treatment', 'type': 'OTHER', 'description': 'Usual care in the partner CMHCs typically starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).', 'armGroupLabels': ['UC-DT']}]}, 'contactsLocationsModule': {'locations': [{'zip': '94520', 'city': 'Concord', 'state': 'California', 'country': 'United States', 'facility': 'Contra Costa Health, Housing, and Homeless Services Division', 'geoPoint': {'lat': 37.97798, 'lon': -122.03107}}, {'zip': '94533', 'city': 'Fairfield', 'state': 'California', 'country': 'United States', 'facility': 'Solano County Department of Health & Social Services, Behavioral Health Services', 'geoPoint': {'lat': 38.24936, 'lon': -122.03997}}, {'zip': '93230', 'city': 'Hanford', 'state': 'California', 'country': 'United States', 'facility': 'Kings County Behavioral Health', 'geoPoint': {'lat': 36.32745, 'lon': -119.64568}}, {'zip': '95458', 'city': 'Lucerne', 'state': 'California', 'country': 'United States', 'facility': 'Lake County Behavioral Health Services', 'geoPoint': {'lat': 36.38078, 'lon': -119.6643}}, {'zip': '94606', 'city': 'Oakland', 'state': 'California', 'country': 'United States', 'facility': 'Alameda County Behavioral Health Care Services', 'geoPoint': {'lat': 37.80437, 'lon': -122.2708}}, {'zip': '95678', 'city': 'Roseville', 'state': 'California', 'country': 'United States', 'facility': 'Placer County Health and Human Services, Adult System of Care', 'geoPoint': {'lat': 38.75212, 'lon': -121.28801}}, {'zip': '93906', 'city': 'Salinas', 'state': 'California', 'country': 'United States', 'facility': 'Monterey County Behavioral Health', 'geoPoint': {'lat': 36.67774, 'lon': -121.6555}}, {'zip': '95148', 'city': 'San Jose', 'state': 'California', 'country': 'United States', 'facility': 'Bay Area Community Health', 'geoPoint': {'lat': 37.33939, 'lon': -121.89496}}, {'zip': '95060', 'city': 'Santa Cruz', 'state': 'California', 'country': 'United States', 'facility': 'County of Santa Cruz Behavioral Health Services for Children and Adults', 'geoPoint': {'lat': 36.97412, 'lon': -122.0308}}], 'overallOfficials': [{'name': 'Allison Harvey, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University of California, Berkeley'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of California, Berkeley', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}